What regulation governs the requirements for patent applications with nucleotide and/or amino acid sequence disclosures?
The requirements for patent applications with nucleotide and/or amino acid sequence disclosures are governed by 37 CFR 1.831. This is referenced in MPEP 2412.03(c): 37 CFR 1.831 Requirements for patent applications filed on or after July 1, 2022, having nucleotide and/or amino acid sequence disclosures. This regulation sets forth the specific requirements that patent applicants…
Read MoreWhat are the key regulations implementing restriction practice in patent applications?
What are the key regulations implementing restriction practice in patent applications? The key regulations implementing restriction practice in patent applications are found in 37 CFR 1.141-1.146. These regulations provide specific guidelines for applying restriction requirements. For example: 37 CFR 1.141 outlines the requirements for different types of claims in one application. 37 CFR 1.142 addresses…
Read More